IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
Background : : This study aimed to identify chronicity predictors of pediatric primary immune thrombocytopenia (ITP). Methods : : This study retrospectively reviewed the medical records of patients with primary pediatric ITP admitted to a tertiary medical center between 2010 and 2021. Forty-five pat...
Saved in:
Main Authors: | Min Gi Sakong (Author), Ji Hoon Park (Author), Sang Beom Son (Author), Yu Kyung Kim (Author), Jae Min Lee (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Pediatric Hematology-Oncology,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017) -
Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation
by: Qi Wang, et al.
Published: (2022) -
Treatment of scleromyxedema with IVIg
by: Moser David W, et al.
Published: (2012) -
Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023) -
Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report
by: Mia Gonzales MD, MPH, et al.
Published: (2019)